{"id":7635,"date":"2018-03-29T11:10:42","date_gmt":"2018-03-29T11:10:42","guid":{"rendered":"https:\/\/mda.brandncraft.com\/?p=7635"},"modified":"2026-01-27T14:11:55","modified_gmt":"2026-01-27T14:11:55","slug":"lutilisation-des-tests-de-biomarqueurs-par-les-oncologues-est-en-augmentation-mais-des-possibilites-dutilisation-accrue-demeurent","status":"publish","type":"post","link":"https:\/\/mda.brandncraft.com\/fr\/donnees-du-sondage\/donnees-du-sondage-canada\/lutilisation-des-tests-de-biomarqueurs-par-les-oncologues-est-en-augmentation-mais-des-possibilites-dutilisation-accrue-demeurent\/","title":{"rendered":"L\u2019utilisation des tests de biomarqueurs par les oncologues est en augmentation, mais des possibilit\u00e9s d\u2019utilisation accrue demeurent"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"<p>Les biomarqueurs sont des mol\u00e9cules pr\u00e9sentes dans les fluides corporels ou les tissus (y compris le tissu tumoral). Ils fournissent des informations pr\u00e9cieuses sur les cellules canc\u00e9reuses et non canc\u00e9reuses lors de l&rsquo;analyse des biomarqueurs produits en r\u00e9ponse au cancer. En d\u00e9veloppant un profil de biomarqueurs du cancer d\u2019un patient, les m\u00e9decins peuvent recommander le plan de traitement le mieux adapt\u00e9 \u00e0 leur patient.<\/p>\n","protected":false},"author":8,"featured_media":7645,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[62],"tags":[],"country-icon":[45,44],"class_list":["post-7635","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-donnees-du-sondage-canada","country-icon-canada","country-icon-united-states"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Croissance des tests de biomarqueurs | Test de biomarqueurs en oncologie MD Analytics<\/title>\n<meta name=\"description\" content=\"Nous avons interrog\u00e9 32 oncologues canadiens sur la croissance des tests de biomarqueurs, les possibilit\u00e9s et le r\u00f4le qu&#039;ils jouent sur la prise en charge du cancer.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mda.brandncraft.com\/fr\/donnees-du-sondage\/donnees-du-sondage-canada\/lutilisation-des-tests-de-biomarqueurs-par-les-oncologues-est-en-augmentation-mais-des-possibilites-dutilisation-accrue-demeurent\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Croissance des tests de biomarqueurs | Test de biomarqueurs en oncologie MD Analytics\" \/>\n<meta property=\"og:description\" content=\"Nous avons interrog\u00e9 32 oncologues canadiens sur la croissance des tests de biomarqueurs, les possibilit\u00e9s et le r\u00f4le qu&#039;ils jouent sur la prise en charge du cancer.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mda.brandncraft.com\/fr\/donnees-du-sondage\/donnees-du-sondage-canada\/lutilisation-des-tests-de-biomarqueurs-par-les-oncologues-est-en-augmentation-mais-des-possibilites-dutilisation-accrue-demeurent\/\" \/>\n<meta property=\"og:site_name\" content=\"MD Analytics\" \/>\n<meta property=\"article:published_time\" content=\"2018-03-29T11:10:42+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-27T14:11:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mda.brandncraft.com\/wp-content\/uploads\/2018\/03\/les-biomarqueurs-en-cancerologie_FR-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Daniel Turner, VP Client Services\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Daniel Turner, VP Client Services\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/donnees-du-sondage\\\/donnees-du-sondage-canada\\\/lutilisation-des-tests-de-biomarqueurs-par-les-oncologues-est-en-augmentation-mais-des-possibilites-dutilisation-accrue-demeurent\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/donnees-du-sondage\\\/donnees-du-sondage-canada\\\/lutilisation-des-tests-de-biomarqueurs-par-les-oncologues-est-en-augmentation-mais-des-possibilites-dutilisation-accrue-demeurent\\\/\"},\"author\":{\"name\":\"Daniel Turner, VP Client Services\",\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/#\\\/schema\\\/person\\\/218842d011574fcb0bdfc3f3a5bb5e7f\"},\"headline\":\"L\u2019utilisation des tests de biomarqueurs par les oncologues est en augmentation, mais des possibilit\u00e9s d\u2019utilisation accrue demeurent\",\"datePublished\":\"2018-03-29T11:10:42+00:00\",\"dateModified\":\"2026-01-27T14:11:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/donnees-du-sondage\\\/donnees-du-sondage-canada\\\/lutilisation-des-tests-de-biomarqueurs-par-les-oncologues-est-en-augmentation-mais-des-possibilites-dutilisation-accrue-demeurent\\\/\"},\"wordCount\":20,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/donnees-du-sondage\\\/donnees-du-sondage-canada\\\/lutilisation-des-tests-de-biomarqueurs-par-les-oncologues-est-en-augmentation-mais-des-possibilites-dutilisation-accrue-demeurent\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mda.brandncraft.com\\\/wp-content\\\/uploads\\\/2018\\\/03\\\/les-biomarqueurs-en-cancerologie_FR-1.png\",\"articleSection\":[\"R\u00e9sultats des sondages Canada\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/donnees-du-sondage\\\/donnees-du-sondage-canada\\\/lutilisation-des-tests-de-biomarqueurs-par-les-oncologues-est-en-augmentation-mais-des-possibilites-dutilisation-accrue-demeurent\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/donnees-du-sondage\\\/donnees-du-sondage-canada\\\/lutilisation-des-tests-de-biomarqueurs-par-les-oncologues-est-en-augmentation-mais-des-possibilites-dutilisation-accrue-demeurent\\\/\",\"url\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/donnees-du-sondage\\\/donnees-du-sondage-canada\\\/lutilisation-des-tests-de-biomarqueurs-par-les-oncologues-est-en-augmentation-mais-des-possibilites-dutilisation-accrue-demeurent\\\/\",\"name\":\"Croissance des tests de biomarqueurs | Test de biomarqueurs en oncologie MD Analytics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/donnees-du-sondage\\\/donnees-du-sondage-canada\\\/lutilisation-des-tests-de-biomarqueurs-par-les-oncologues-est-en-augmentation-mais-des-possibilites-dutilisation-accrue-demeurent\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/donnees-du-sondage\\\/donnees-du-sondage-canada\\\/lutilisation-des-tests-de-biomarqueurs-par-les-oncologues-est-en-augmentation-mais-des-possibilites-dutilisation-accrue-demeurent\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mda.brandncraft.com\\\/wp-content\\\/uploads\\\/2018\\\/03\\\/les-biomarqueurs-en-cancerologie_FR-1.png\",\"datePublished\":\"2018-03-29T11:10:42+00:00\",\"dateModified\":\"2026-01-27T14:11:55+00:00\",\"description\":\"Nous avons interrog\u00e9 32 oncologues canadiens sur la croissance des tests de biomarqueurs, les possibilit\u00e9s et le r\u00f4le qu'ils jouent sur la prise en charge du cancer.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/donnees-du-sondage\\\/donnees-du-sondage-canada\\\/lutilisation-des-tests-de-biomarqueurs-par-les-oncologues-est-en-augmentation-mais-des-possibilites-dutilisation-accrue-demeurent\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/donnees-du-sondage\\\/donnees-du-sondage-canada\\\/lutilisation-des-tests-de-biomarqueurs-par-les-oncologues-est-en-augmentation-mais-des-possibilites-dutilisation-accrue-demeurent\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/donnees-du-sondage\\\/donnees-du-sondage-canada\\\/lutilisation-des-tests-de-biomarqueurs-par-les-oncologues-est-en-augmentation-mais-des-possibilites-dutilisation-accrue-demeurent\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mda.brandncraft.com\\\/wp-content\\\/uploads\\\/2018\\\/03\\\/les-biomarqueurs-en-cancerologie_FR-1.png\",\"contentUrl\":\"https:\\\/\\\/mda.brandncraft.com\\\/wp-content\\\/uploads\\\/2018\\\/03\\\/les-biomarqueurs-en-cancerologie_FR-1.png\",\"width\":900,\"height\":500,\"caption\":\"les biomarqueurs en cancerologie\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/donnees-du-sondage\\\/donnees-du-sondage-canada\\\/lutilisation-des-tests-de-biomarqueurs-par-les-oncologues-est-en-augmentation-mais-des-possibilites-dutilisation-accrue-demeurent\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"L\u2019utilisation des tests de biomarqueurs par les oncologues est en augmentation, mais des possibilit\u00e9s d\u2019utilisation accrue demeurent\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/\",\"name\":\"MD Analytics\",\"description\":\"Health And Pharmaceutical Market Research | MD Analytics ULC\",\"publisher\":{\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/#organization\",\"name\":\"MD Analytics Inc.\",\"url\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":null,\"contentUrl\":null,\"width\":null,\"height\":null,\"caption\":\"MD Analytics Inc.\"},\"image\":{\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/#\\\/schema\\\/person\\\/218842d011574fcb0bdfc3f3a5bb5e7f\",\"name\":\"Daniel Turner, VP Client Services\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/mda.brandncraft.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/Circle-DanT-1-150x150.png\",\"url\":\"https:\\\/\\\/mda.brandncraft.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/Circle-DanT-1-150x150.png\",\"contentUrl\":\"https:\\\/\\\/mda.brandncraft.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/Circle-DanT-1-150x150.png\",\"caption\":\"Daniel Turner, VP Client Services\"},\"url\":\"https:\\\/\\\/mda.brandncraft.com\\\/fr\\\/author\\\/dturner\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Croissance des tests de biomarqueurs | Test de biomarqueurs en oncologie MD Analytics","description":"Nous avons interrog\u00e9 32 oncologues canadiens sur la croissance des tests de biomarqueurs, les possibilit\u00e9s et le r\u00f4le qu'ils jouent sur la prise en charge du cancer.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mda.brandncraft.com\/fr\/donnees-du-sondage\/donnees-du-sondage-canada\/lutilisation-des-tests-de-biomarqueurs-par-les-oncologues-est-en-augmentation-mais-des-possibilites-dutilisation-accrue-demeurent\/","og_locale":"fr_FR","og_type":"article","og_title":"Croissance des tests de biomarqueurs | Test de biomarqueurs en oncologie MD Analytics","og_description":"Nous avons interrog\u00e9 32 oncologues canadiens sur la croissance des tests de biomarqueurs, les possibilit\u00e9s et le r\u00f4le qu'ils jouent sur la prise en charge du cancer.","og_url":"https:\/\/mda.brandncraft.com\/fr\/donnees-du-sondage\/donnees-du-sondage-canada\/lutilisation-des-tests-de-biomarqueurs-par-les-oncologues-est-en-augmentation-mais-des-possibilites-dutilisation-accrue-demeurent\/","og_site_name":"MD Analytics","article_published_time":"2018-03-29T11:10:42+00:00","article_modified_time":"2026-01-27T14:11:55+00:00","og_image":[{"width":900,"height":500,"url":"https:\/\/mda.brandncraft.com\/wp-content\/uploads\/2018\/03\/les-biomarqueurs-en-cancerologie_FR-1.png","type":"image\/png"}],"author":"Daniel Turner, VP Client Services","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Daniel Turner, VP Client Services","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mda.brandncraft.com\/fr\/donnees-du-sondage\/donnees-du-sondage-canada\/lutilisation-des-tests-de-biomarqueurs-par-les-oncologues-est-en-augmentation-mais-des-possibilites-dutilisation-accrue-demeurent\/#article","isPartOf":{"@id":"https:\/\/mda.brandncraft.com\/fr\/donnees-du-sondage\/donnees-du-sondage-canada\/lutilisation-des-tests-de-biomarqueurs-par-les-oncologues-est-en-augmentation-mais-des-possibilites-dutilisation-accrue-demeurent\/"},"author":{"name":"Daniel Turner, VP Client Services","@id":"https:\/\/mda.brandncraft.com\/fr\/#\/schema\/person\/218842d011574fcb0bdfc3f3a5bb5e7f"},"headline":"L\u2019utilisation des tests de biomarqueurs par les oncologues est en augmentation, mais des possibilit\u00e9s d\u2019utilisation accrue demeurent","datePublished":"2018-03-29T11:10:42+00:00","dateModified":"2026-01-27T14:11:55+00:00","mainEntityOfPage":{"@id":"https:\/\/mda.brandncraft.com\/fr\/donnees-du-sondage\/donnees-du-sondage-canada\/lutilisation-des-tests-de-biomarqueurs-par-les-oncologues-est-en-augmentation-mais-des-possibilites-dutilisation-accrue-demeurent\/"},"wordCount":20,"commentCount":0,"publisher":{"@id":"https:\/\/mda.brandncraft.com\/fr\/#organization"},"image":{"@id":"https:\/\/mda.brandncraft.com\/fr\/donnees-du-sondage\/donnees-du-sondage-canada\/lutilisation-des-tests-de-biomarqueurs-par-les-oncologues-est-en-augmentation-mais-des-possibilites-dutilisation-accrue-demeurent\/#primaryimage"},"thumbnailUrl":"https:\/\/mda.brandncraft.com\/wp-content\/uploads\/2018\/03\/les-biomarqueurs-en-cancerologie_FR-1.png","articleSection":["R\u00e9sultats des sondages Canada"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/mda.brandncraft.com\/fr\/donnees-du-sondage\/donnees-du-sondage-canada\/lutilisation-des-tests-de-biomarqueurs-par-les-oncologues-est-en-augmentation-mais-des-possibilites-dutilisation-accrue-demeurent\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/mda.brandncraft.com\/fr\/donnees-du-sondage\/donnees-du-sondage-canada\/lutilisation-des-tests-de-biomarqueurs-par-les-oncologues-est-en-augmentation-mais-des-possibilites-dutilisation-accrue-demeurent\/","url":"https:\/\/mda.brandncraft.com\/fr\/donnees-du-sondage\/donnees-du-sondage-canada\/lutilisation-des-tests-de-biomarqueurs-par-les-oncologues-est-en-augmentation-mais-des-possibilites-dutilisation-accrue-demeurent\/","name":"Croissance des tests de biomarqueurs | Test de biomarqueurs en oncologie MD Analytics","isPartOf":{"@id":"https:\/\/mda.brandncraft.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/mda.brandncraft.com\/fr\/donnees-du-sondage\/donnees-du-sondage-canada\/lutilisation-des-tests-de-biomarqueurs-par-les-oncologues-est-en-augmentation-mais-des-possibilites-dutilisation-accrue-demeurent\/#primaryimage"},"image":{"@id":"https:\/\/mda.brandncraft.com\/fr\/donnees-du-sondage\/donnees-du-sondage-canada\/lutilisation-des-tests-de-biomarqueurs-par-les-oncologues-est-en-augmentation-mais-des-possibilites-dutilisation-accrue-demeurent\/#primaryimage"},"thumbnailUrl":"https:\/\/mda.brandncraft.com\/wp-content\/uploads\/2018\/03\/les-biomarqueurs-en-cancerologie_FR-1.png","datePublished":"2018-03-29T11:10:42+00:00","dateModified":"2026-01-27T14:11:55+00:00","description":"Nous avons interrog\u00e9 32 oncologues canadiens sur la croissance des tests de biomarqueurs, les possibilit\u00e9s et le r\u00f4le qu'ils jouent sur la prise en charge du cancer.","breadcrumb":{"@id":"https:\/\/mda.brandncraft.com\/fr\/donnees-du-sondage\/donnees-du-sondage-canada\/lutilisation-des-tests-de-biomarqueurs-par-les-oncologues-est-en-augmentation-mais-des-possibilites-dutilisation-accrue-demeurent\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mda.brandncraft.com\/fr\/donnees-du-sondage\/donnees-du-sondage-canada\/lutilisation-des-tests-de-biomarqueurs-par-les-oncologues-est-en-augmentation-mais-des-possibilites-dutilisation-accrue-demeurent\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/mda.brandncraft.com\/fr\/donnees-du-sondage\/donnees-du-sondage-canada\/lutilisation-des-tests-de-biomarqueurs-par-les-oncologues-est-en-augmentation-mais-des-possibilites-dutilisation-accrue-demeurent\/#primaryimage","url":"https:\/\/mda.brandncraft.com\/wp-content\/uploads\/2018\/03\/les-biomarqueurs-en-cancerologie_FR-1.png","contentUrl":"https:\/\/mda.brandncraft.com\/wp-content\/uploads\/2018\/03\/les-biomarqueurs-en-cancerologie_FR-1.png","width":900,"height":500,"caption":"les biomarqueurs en cancerologie"},{"@type":"BreadcrumbList","@id":"https:\/\/mda.brandncraft.com\/fr\/donnees-du-sondage\/donnees-du-sondage-canada\/lutilisation-des-tests-de-biomarqueurs-par-les-oncologues-est-en-augmentation-mais-des-possibilites-dutilisation-accrue-demeurent\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/mda.brandncraft.com\/fr\/"},{"@type":"ListItem","position":2,"name":"L\u2019utilisation des tests de biomarqueurs par les oncologues est en augmentation, mais des possibilit\u00e9s d\u2019utilisation accrue demeurent"}]},{"@type":"WebSite","@id":"https:\/\/mda.brandncraft.com\/fr\/#website","url":"https:\/\/mda.brandncraft.com\/fr\/","name":"MD Analytics","description":"Health And Pharmaceutical Market Research | MD Analytics ULC","publisher":{"@id":"https:\/\/mda.brandncraft.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mda.brandncraft.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/mda.brandncraft.com\/fr\/#organization","name":"MD Analytics Inc.","url":"https:\/\/mda.brandncraft.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/mda.brandncraft.com\/fr\/#\/schema\/logo\/image\/","url":null,"contentUrl":null,"width":null,"height":null,"caption":"MD Analytics Inc."},"image":{"@id":"https:\/\/mda.brandncraft.com\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/mda.brandncraft.com\/fr\/#\/schema\/person\/218842d011574fcb0bdfc3f3a5bb5e7f","name":"Daniel Turner, VP Client Services","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/mda.brandncraft.com\/wp-content\/uploads\/2026\/01\/Circle-DanT-1-150x150.png","url":"https:\/\/mda.brandncraft.com\/wp-content\/uploads\/2026\/01\/Circle-DanT-1-150x150.png","contentUrl":"https:\/\/mda.brandncraft.com\/wp-content\/uploads\/2026\/01\/Circle-DanT-1-150x150.png","caption":"Daniel Turner, VP Client Services"},"url":"https:\/\/mda.brandncraft.com\/fr\/author\/dturner\/"}]}},"_links":{"self":[{"href":"https:\/\/mda.brandncraft.com\/fr\/wp-json\/wp\/v2\/posts\/7635","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mda.brandncraft.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mda.brandncraft.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mda.brandncraft.com\/fr\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/mda.brandncraft.com\/fr\/wp-json\/wp\/v2\/comments?post=7635"}],"version-history":[{"count":1,"href":"https:\/\/mda.brandncraft.com\/fr\/wp-json\/wp\/v2\/posts\/7635\/revisions"}],"predecessor-version":[{"id":7647,"href":"https:\/\/mda.brandncraft.com\/fr\/wp-json\/wp\/v2\/posts\/7635\/revisions\/7647"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mda.brandncraft.com\/fr\/wp-json\/wp\/v2\/media\/7645"}],"wp:attachment":[{"href":"https:\/\/mda.brandncraft.com\/fr\/wp-json\/wp\/v2\/media?parent=7635"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mda.brandncraft.com\/fr\/wp-json\/wp\/v2\/categories?post=7635"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mda.brandncraft.com\/fr\/wp-json\/wp\/v2\/tags?post=7635"},{"taxonomy":"country-icon","embeddable":true,"href":"https:\/\/mda.brandncraft.com\/fr\/wp-json\/wp\/v2\/country-icon?post=7635"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}